(Boehringer Ingelheim) Aaron has engaged with Congressional members and the FDA on outreach to Hispanic groups about the dangers of purchasing counterfeit medications from unauthorized retailers. He also advocates on drug take-back programs, anti-counterfeiting and protection of BI’s extensive supply chain.
J. Aaron Graham
